Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 3.77% |
UNITEDHEALTH GROUP INC. | UNH | 3.25% |
JOHNSON & JOHNSON | JNJ | 2.89% |
ABBVIE INC | ABBV | 2.66% |
MERCK & COMPANY, INC. | MRK | 2.41% |
THERMO FISHER SCIENTIFIC | TMO | 2.30% |
INTUITIVE SURGICAL, INC. | ISRG | 2.25% |
ABBOTT LABORATORIES | ABT | 2.13% |
DANAHER CORPORATION | DHR | 1.94% |
PFIZER INC | PFE | 1.90% |
BOSTON SCIENTIFIC CORP | BSX | 1.90% |
AMGEN INC. | AMGN | 1.82% |
STRYKER CORP | SYK | 1.76% |
BRISTOL MYERS SQUIBB CO | BMY | 1.63% |
GILEAD SCIENCES, INC. | GILD | 1.61% |
VERTEX PHARMACEUTICALS | VRTX | 1.50% |
ELEVANCE HEALTH INC | ANTM | 1.44% |
THE CIGNA GROUP | CI | 1.33% |
MCKESSON CORPORATION | MCK | 1.33% |
REGENERON PHARMACEUTICALS | REGN | 1.27% |
BECTON DICKINSON & CO | BDX | 1.27% |
CVS HEALTH CORP. | CVS | 1.25% |
ZOETIS INC | ZTS | 1.24% |
ASTRAZENECA PLC ADR | AZN | 1.17% |
HCA HEALTCARE INC | HCA | 1.13% |
MEDTRONIC PLC | MDT | 1.11% |
CENCORA INC | ABC | 1.00% |
AGILENT TECHNOLOGIES, INC | A | 0.99% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.96% |
EDWARDS LIFESCIENCES CORP | EW | 0.94% |
DEXCOM INC | DXCM | 0.90% |
ICON PLC | ICLR | 0.90% |
IQVIA HOLDINGS INC | IQV | 0.89% |
IDEXX LABORATORIES INC | IDXX | 0.89% |
CENTENE CORP | CNC | 0.88% |
RESMED INC | RMD | 0.87% |
HUMANA, INC. | HUM | 0.87% |
CARDINAL HEALTH, INC. | CAH | 0.87% |
TEVA PHARMACEUTICAL | TEVA | 0.87% |
ALNYLAM PHARMACEUTICALS | ALNY | 0.86% |
VEEVA SYSTEMS-A | VEEV | 0.82% |
ARGENX SE - ADR | ARGX | 0.78% |
WATERS CORPORATION | WAT | 0.77% |
WEST PHARMACEUTICAL SERVI | WST | 0.75% |
NOVO-NORDISK A/S -ADR | NVO | 0.72% |
GSK PLC-SPON ADR | GSK-W | 0.72% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.71% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.70% |
NATERA INC | NTRA | 0.70% |
ILLUMINA INC | ILMN | 0.69% |
LABCORP HOLDINGS INC | LH | 0.68% |
STERIS PLC | STE | 0.68% |
ALKERMES PLC | ALKS | 0.67% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.67% |
NOVARTIS ADR | NVS | 0.66% |
INTRA-CELLULAR T | ITCI | 0.66% |
BIOGEN IDEC, INC. | BIIB | 0.66% |
INSULET CORP | PODD | 0.66% |
COOPER COS INC/THE | COO | 0.64% |
UNITED THERAPEUTICS CORP | UTHR | 0.61% |
BIONTECH SE-ADR | BNTX | 0.61% |
QUEST DIAGNOSTICS, INC. | DGX | 0.61% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.61% |
BAXTER INTERNATIONAL | BAX | 0.60% |
AVANTOR INC | AVTR | 0.59% |
MOLINA HEALTHCARE INC | MOH | 0.58% |
HOLOGIC, INC. | HOLX | 0.58% |
ALIGN TECHNOLOGY | ALGN | 0.57% |
CRISPR THERAPEUTICS AG | CRSP | 0.57% |
INSMED INC | INSM | 0.55% |
TENET HEALTHCARE CORP | THC | 0.53% |
BIO-TECHNE CORP | TECH | 0.52% |
INCYTE CORP | INCY | 0.52% |
VIATRIS INC | VTRS | 0.51% |
UNIVERSAL HEALTH SERVICES | UHS | 0.51% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.50% |
EXELIXIS, INC. | EXEL | 0.49% |
VAXCYTE INC | PCVX | 0.49% |
SAREPTA THERAPEU | SRPT | 0.48% |
MODERNA INC | MRNA | 0.46% |
REPLIGEN CORP | RGEN | 0.46% |
HEALTHEQUITY INC | HQY | 0.45% |
HENRY SCHEIN, INC. | HSIC | 0.44% |
MASIMO CORP | MASI | 0.43% |
HALOZYME THERAPEUTICS INC | HALO | 0.43% |
ENSIGN GROUP INC/THE | ENSG | 0.41% |
DAVITA, INC | DVA | 0.41% |
CHARLES RIVER LAB INTER | CRL | 0.41% |
BLUEPRINT MEDICI | BPMC | 0.41% |
EXACT SCIENCES | EXAS | 0.40% |
MEDPACE HOLDINGS | MEDP | 0.40% |
BRIDGEBIO PHARMA INC | BBIO | 0.39% |
INARI MEDICAL INC | NARI | 0.39% |
BRUKER CORP | BRKR | 0.38% |
OPTION CARE HEALTH INC | OPCH | 0.38% |
LANTHEUS HOLDING | LNTH | 0.38% |
REVOLUTION MEDICINES INC | RVMD | 0.37% |
MERIT MEDICAL SYSTEMS INC | MMSI | 0.36% |
CYTOKINETICS INC | CYTK | 0.35% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.34% |
GUARDANT HEALTH INC | GH | 0.32% |
CORCEPT THERA | CORT | 0.32% |
ROIVANT SCIENCES LTD | ROIV | 0.32% |
HIMS & HERS HEALTH INC | HIMS | 0.32% |
IONIS PHARMACEUTICALS, IN | IONS | 0.31% |
TG THERAPEUTICS | TGTX | 0.30% |
AXSOME THERAPEUT | AXSM | 0.29% |
ACADIA HEALTHCAR | ACHC | 0.29% |
PROCEPT BIOROBOTICS CORP | PRCT | 0.28% |
ADMA BIOLOGICS INC | ADMA | 0.28% |
DENTSPLY SIRONA, NC. | XRAY | 0.28% |
APELLIS PHARMACE | APLS | 0.26% |
AVIDITY BIOSCIENCES INC | RNA | 0.25% |
TANDEM DIABETES CARE INC | TNDM | 0.25% |
TWIST BIOSCIENCE CORP | TWST | 0.24% |
VIKING THERAPEUTICS INC | VKTX | 0.23% |
CRINETICS PHARMACEUTICALS | CRNX | 0.22% |
MADRIGAL PHARMAC | MDGL | 0.20% |
TRANSMEDICS GROUP INC | TMDX | 0.20% |
KRYSTAL BIOTECH INC | KRYS | 0.18% |
NOVAVAX INC | NVAX | 0.16% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.16% |
Other (Cash, derivatives and other liabilities) | 0.57% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.